THURSDAY, June 16, 2022 (HealthDay News) -- Researchers have figured out a way to safely give children a donor kidney without the need for immune-suppressing drugs -- an advance they hope to expand to many more kidney transplant patients in coming years.
Reporting in the June 15 issue of the New England Journal of Medicine, doctors at Stanford University describe the first three children to be treated with the new approach. It involved giving them not only a new kidney, but a new immune system -- both donated from a parent.
All three children now have normal kidney function, and are free of the anti-rejection drugs that transplant recipients normally have to take every day for the rest of their lives.
Much research remains before the approach can be widely offered, and experts cautioned that the three children in these cases had a rare genetic condition causing their kidney disease.
"This is a great outcome for these children," said Dr. Bradley Warady, director of pediatric nephrology at Children's Mercy Kansas City, in Missouri. "But we can't extrapolate this to all children who need a kidney transplant."
That caveat made, "there's cautious optimism this could become a more widespread procedure," said Warady, who is also on the board of directors for the National Kidney Foundation.
Lead researcher Dr. Alice Bertaina said the findings show a "holy grail" of transplant medicine is achievable.
"The most important thing is, we've shown this is possible," said Bertaina, an associate professor of pediatrics at Stanford.
Freeing kidney transplant recipients from anti-rejection drugs would be a huge advance, both doctors said. Lifelong immune suppression comes with a host of consequences, including heightened risks of serious infections and cancer, as well as conditions like diabetes and high blood pressure.
Dr. Eliza Blanchette, a pediatric nephrologist at Children's Hospital Colorado, pointed to another benefit of negating the need for anti-rejection drugs: Over time, they can actually damage the kidney they are designed to protect. So it's possible that freeing patients from the drugs could prolong the life of a donor kidney.
For years, researchers have sought a way to induce "immune tolerance" for donor organs, so that a lifetime of anti-rejection drugs is unnecessary. One approach is through a stem cell transplant from the organ donor.
Stem cells are primitive cells that give rise to mature cells, including those of the immune system. So, a stem cell transplant from an organ donor essentially provides the recipient with a new immune system that should recognize the donor organ and leave it unscathed.
The problem is that new immune system can also attack the recipient's body, causing a potentially fatal reaction called graft-versus-host disease (GVHD).
"It's been thought that the risk was too high," Bertaina said.
But she and her colleagues developed a protocol to minimize the risks, by refining how the donor stem cells are processed: They deplete the transplant of the particular cells, called alpha-beta T-cells, which cause GVHD.
The three children in the current report all received stem cells from their kidney-donor parent, and then five to 10 months later received the kidney itself. One child did develop mild GVHD, but it was managed with medication.
At this point, all three children have been living with fully functioning kidneys for 22 to 34 months -- without immune-suppressing drugs.
Jessica and Kyle Davenport of Muscle Shoals, Ala., are the parents of two of the children. Jessica was the donor for her 8-year-old son Kruz, while his 7-year-old sister, Paizlee, received transplants from Kyle.
"They've healed and recovered, and are doing things we never thought would be possible," Jessica Davenport said in a Stanford news release.
A major caveat is that all three kids have a rare genetic disorder called Schimke immuno-osseous dysplasia (SIOD). Along with kidney disease, SIOD causes short stature, immune system deficiencies and other problems.
Bertaina said the immune deficiencies seen in SIOD may actually be one reason the transplant approach worked so well for these kids.
Far more often, Warady said, pediatric kidney disease is caused by a birth defect, in children with normal immune function.
"We need more research to see if this is effective for children with an intact immune system," he said.
Blanchette also stressed that the effectiveness for children with normal immune function is not yet known.
Bertaina is hopeful this report will spur additional medical centers to do that kind of research. The Stanford team has already expanded the approach to other patient groups, including children whose bodies rejected a prior kidney transplant.
Those patients, Bertaina said, are generally "hypersensitized," and likely to reject a repeat transplant. So giving them a new immune system first might surmount that obstacle.
The ultimate hope, Bertaina said, is to expand the procedure to children, and adults, with a range of underlying causes for their kidney disease.
At this point, it requires a living donor who is a genetic half-match; for an adult, that could be a sibling or child, Bertaina noted. But the researchers are also hoping to adapt the protocol, to even include transplants from deceased donors.
More information
The Nemours Foundation has more on pediatric kidney disease.
SOURCES: Alice Bertaina, MD, PhD, associate professor, pediatrics, Stanford University School of Medicine, Stanford, Calif.; Bradley Warady, MD, member, board of directors, National Kidney Foundation, New York City, and director, pediatric nephrology/dialysis and transplantation, Children's Mercy Kansas City, Kansas City, Mo.; Eliza Blanchette, MD, pediatric nephrologist, Children's Hospital Colorado; Stanford University, news release, June 15, 2022; New England Journal of Medicine, June 16, 2022
From Your Site Articles
Related Articles Around the Web
Read the original:
Doctors Transplant Kidneys to Children Without Need for Immune ...
- Human cells in a rat's brain could shed light on autism and ADHD - Kansas Public Radio - October 13th, 2022
- California is poised to phase out sales of new gas-powered cars - Kansas Public Radio - August 30th, 2022
- The Future of Parkinson Disease Therapies and the Challenges With Stem Cell Therapies - Neurology Live - June 22nd, 2022
- Chemical Markers That May Unlock Future Therapeutic Uses of mRNA - Lab Manager Magazine - May 2nd, 2022
- Jayhawks shine at 2022 Capitol Graduate Research Summit | The University of Kansas - KU Today - April 19th, 2022
- Four researchers named recipients of the University Scholarly Achievement Award | The University of Kansas - KU Today - March 25th, 2022
- COVID-19 directly damages, creates scar tissue on the kidneys, study finds - WDAF FOX4 Kansas City - January 5th, 2022
- The controversy being created about the origins of the virus that causes COVID-19 - Frontline - July 6th, 2021
- Kelly lauds $21 billion state budget bill, vetoes $500,000 ... - June 6th, 2021
- [Full text] Binding of the SARS-CoV-2 Spike Protein | HMER - Dove Medical Press - April 15th, 2021
- IN8bio announces first-in-human Phase 1 trial Update from The University of Kansas Cancer Center using INB-100, IN8bio's Gamma Delta T-cell product... - December 4th, 2020
- Incysus Therapeutics Announces Name Change to IN8bio, Inc. - GlobeNewswire - August 28th, 2020
- Seeing through a forest of SCN2A gene variation - SFARI News - February 20th, 2020
- FHSU partners with Be the Match for bone marrow registry event - hays Post - February 20th, 2020
- Trial cancer treatment in Wichita - KAKE - December 2nd, 2019
- Infanticide: Live Organ Harvesting Commonplace in US Abortion Mills - Church Militant - October 17th, 2019
- Kansas Regenerative Stem Cell Seminar - Stem Cell Centers ... - September 10th, 2019
- Stem Cell Procedures | Motus Biologics of Kansas City - September 9th, 2019
- Stem Cell Therapy in Kansas City- Rejuvenate KC | Stem ... - April 26th, 2019
- Hip Stem Cell Treatment | Motus Biologics in Kansas City - January 23rd, 2019
- About Stem Cell Therapy - Kansas Regenerative Medicine - November 29th, 2018
- Stem Cell Therapy in Wichita, Kansas | Joint Pain Relief ... - October 6th, 2018
- Kansas Stem Cell Center Close To First Clinical Trial | KCUR - August 27th, 2018
- Knee Stem Cell Treatments in Kansas City | Motus Biologics - August 2nd, 2018
- Stem cells relieve chronic pain in Kansas City, MO - July 30th, 2018
- Adult Stem Cell Therapy 101, MSCTC - University of Kansas ... - July 7th, 2018
- Stem cells or Knee surgery - Kansas Regenerative Medicine - June 28th, 2018
- Future Fertility Fix? Egg-Producing Stem Cells Found in ... - October 14th, 2017
- Regenexx Kansas City | Helping your body heal itself - September 24th, 2017
- Feared Zika virus kills brain cancer stem cells, new research shows - Kansas City Star - September 8th, 2017
- Shawnee Woman Was Among First In The World To Undergo New FDA-Approved Cancer Therapy - KCUR - September 8th, 2017
- Paralyzed after pool accident, student heads back to college - Kansas City Star - August 30th, 2017
- About Us, Midwest Stem Cell Therapy Center - KUMC - August 30th, 2017
- Join Jon Kempin, LA Galaxy Foundation and Gift of Life Marrow Registry for Kick Blood Cancer on August 13 - LA Galaxy - August 12th, 2017
- Regenerative Medicine Market in the US - Forecasts, Segmentation, and Opportunity Assessment by Technavio - Business Wire (press release) - August 8th, 2017
- International Space Station's Crew Restored to Six People - Kansas City infoZine - July 30th, 2017
- Scientists build DNA from scratch to alter life's blueprint - Kansas City Star - July 30th, 2017
- Stem Cell Collection - University of Kansas Hospital - October 30th, 2016
- Stem Cell Therapy - North Kansas City Hospital, Kansas ... - October 14th, 2016
- Stem Cell Therapy | Kansas RMC - August 3rd, 2016
- Kansas to Build First US Stem Cell Research Center | CorCell - August 3rd, 2016
- Stem cell program - University of Kansas Medical Center - August 3rd, 2016
- Stem Cell Therapy for Urological Issues | Kansas RMC - July 29th, 2016
- Kansas Regenerative Medicine Center - October 19th, 2015
- Egg Stem Cells - MIT Technology Review - September 27th, 2015
- Doctors in Kansas who treat or diagnose Stem Cell Transplant - August 1st, 2015
- Stem Cells for Paralysis: First of Its Kind Study - April 7th, 2015
- Topeka retailer honored as 'business of the year' - March 7th, 2015
- Saint Lukes Mid America Heart Institute Offers Tips & Treatments For Heart Failure Awareness Week 2015 - February 10th, 2015
- Exploring Stem Cell Therapy for Cerebral Palsy | See the Seitz - December 12th, 2014
- Therapeutic potential of human induced pluripotent stem ... - November 5th, 2014
- Advisory Board, Midwest Stem Cell Therapy Center - November 2nd, 2014
- Myocardial infarction and stem cells - National Center for ... - October 31st, 2014
- Precise and programmable biological circuits - October 24th, 2014
- Stowers Researchers Reveal Molecular Competition Drives ... - September 6th, 2014
- Midwest Stem Cell Therapy Center, University of Kansas ... - September 1st, 2014
- Stem Cell History | A History of Stem Cell Research - August 23rd, 2014
- Kansas City MO Resources - Stem Cells: Get Facts on Uses ... - August 22nd, 2014